[
    [
        {
            "time": "",
            "original_text": "[买入评级]凯莱英(002821)一季报点评：业绩符合预期 国内业务有望加速",
            "features": {
                "keywords": [
                    "凯莱英",
                    "一季报",
                    "业绩",
                    "国内业务",
                    "加速"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]凯莱英(002821)一季报点评：业绩符合预期 国内业务有望加速",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[强烈推荐评级]凯莱英(002821)一季报点评：一季度盈利明显增长 汇兑损益严重 内生增速超高",
            "features": {
                "keywords": [
                    "凯莱英",
                    "一季报",
                    "盈利增长",
                    "汇兑损益",
                    "内生增速"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强烈推荐评级]凯莱英(002821)一季报点评：一季度盈利明显增长 汇兑损益严重 内生增速超高",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[强烈推荐评级]凯莱英(002821)季报点评：一季度运营顺利 高增长有望持续",
            "features": {
                "keywords": [
                    "凯莱英",
                    "季报",
                    "运营顺利",
                    "高增长",
                    "持续"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强烈推荐评级]凯莱英(002821)季报点评：一季度运营顺利 高增长有望持续",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]